They also emphasized that the diagnosis of GH–PRL co-secretion may be underdiagnosed in patients with PRL-secreting PitNETs since it is known that dopamine-D2 agonist decreases IGF1 levels in patients with acromegaly. The gene discussed is PRL; the disease is acromegaly.